Progyny Stock News

Progyny (NASDAQ:PGNY) issued an update on its FY 2021 earnings guidance on Thursday morning. The company provided EPS guidance of $0.510-$0.540 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.470. The company issued revenue guidance of $507 million-$514 million, compared to the consensus revenue estimate of $519.14 million.Progyny also updated its []

Progyny Inc. (NASDAQ:PGNY) shares, rose in value on Wednesday, 11/24/21, with the stock price down by -2.60% to the previous days close as strong demand from buyers drove the stock to $53.29. Actively observing the price movement in the last trading, the stock closed the session at $54.71, falling within a range of $52.13 and Analysts Predict An Progyny Inc. (NASDAQ: PGNY) Spike? Read More »

Shares of Progyny, Inc. (NASDAQ:PGNY) have been given a consensus recommendation of Buy by the eight brokerages that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price among analysts that []

Related Stocks: COMP , OSCR , PGNY , EWCZ , JYNT , PAR , UPLD ,

Related Stocks: LI , LYV , GLBE , BURL , PGNY , COMP , HYFM , XPEV , FUTU , FB , UBER , VRNS , DOCS ,

1832 Asset Management L.P. acquired a new stake in Progyny, Inc. (NASDAQ:PGNY) in the 2nd quarter, Holdings Channel.com reports. The institutional investor acquired 132,800 shares of the companys stock, valued at approximately $8,113,000. A number of other large investors have also recently modified their holdings of the business. Macquarie Group Ltd. grew its position in []

Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2021 Results - Earnings Call Transcript

Progyny (PGNY) delivered earnings and revenue surprises of 142.86% and -2.39%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Progyny: Continued Profitable Growth, Formidable Brand Point To Exciting Upside

The stock price of Progyny (NASDAQ: PGNY), a benefits management company that specializes in fertility and family building benefits solutions, has seen a rise of around 25% over the last month (twenty

NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States,

When a founder-led company is profitably chasing a huge market and having early success, the stock is worth a closer look.

The Zacks Medical - Services industry is growing on digital healthcare adoption. HQY, PGNY, SGRY, MODV, and AGTI are set to gain the most.

Progyny's (PGNY) CEO David Schlanger on Q2 2021 Results - Earnings Call Transcript